DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 113 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,107,000 | +145.2% | 203,680 | +353.8% | 0.04% | +133.3% |
| Q2 2021 | $1,675,000 | +82.1% | 44,885 | +24.7% | 0.02% | +63.6% |
| Q1 2021 | $920,000 | +178.8% | 36,002 | +141.0% | 0.01% | +175.0% |
| Q4 2020 | $330,000 | -69.3% | 14,938 | -75.0% | 0.00% | -80.0% |
| Q3 2020 | $1,075,000 | -9.7% | 59,744 | +27.5% | 0.02% | +25.0% |
| Q2 2020 | $1,190,000 | +438.5% | 46,864 | +367.0% | 0.02% | +220.0% |
| Q4 2019 | $221,000 | -66.5% | 10,036 | -78.1% | 0.01% | -73.7% |
| Q3 2019 | $659,000 | -74.4% | 45,900 | -72.0% | 0.02% | -79.1% |
| Q2 2019 | $2,578,000 | +180.8% | 163,700 | +90.6% | 0.09% | +160.0% |
| Q4 2018 | $918,000 | -78.4% | 85,900 | -69.1% | 0.04% | -81.5% |
| Q3 2018 | $4,247,000 | +670.8% | 278,300 | +518.4% | 0.19% | +530.0% |
| Q2 2018 | $551,000 | -40.2% | 45,000 | -53.3% | 0.03% | -56.5% |
| Q1 2018 | $921,000 | – | 96,268 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |